COVID-19 may lead to delays in treatment for gynecologic cancers
Delays or discontinuation of cancer treatment due to COVID-19 occurred for 28% of the patients in a recent study, with chemotherapy and surgery being the most frequently delayed treatments, the study authors noted. Photo by klbz/pixabay https://pixabay.com/en/chemotherapy-chemo-infusion-cancer-448578/ A COVID-19 diagnosis can lead to potentially life-threatening treatment delays for women with gynecological cancers, a new study…Continue Reading